SCHEMBL19832215

SCHEMBL19832215

N#CCC1(n2cc(-c3c[nH]c4ncccc34)cn2)CC[S+]([O-])CC1

nearest known ligand 0.74

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 18/20 0.74
JAK1 P23458 15/20 0.51
JAK3 P52333 6/20 0.51
TYK2 P29597 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24261752 0.86 JAK2 (0.66) JAK2JAK1JAK3TYK2
SCHEMBL19832220 0.85 JAK2 (1.00) JAK2JAK1JAK3TYK2
SCHEMBL19831989 0.83 JAK2 (0.75) JAK2JAK1JAK3TYK2
SCHEMBL19832171 0.83 JAK1 (0.60) JAK2JAK1JAK3
SCHEMBL19831987 0.82 JAK2 (1.00) JAK2JAK1JAK3TYK2
SCHEMBL21320195 0.80 JAK2 (0.72) JAK2JAK1JAK3TYK2
SCHEMBL21044799 0.80 JAK2 (1.00) JAK2JAK1JAK3TYK2
SCHEMBL24261767 0.79 JAK2 (0.73) JAK2JAK1JAK3TYK2
SCHEMBL19832020 0.79 JAK1 (0.83) JAK2JAK1JAK3
SCHEMBL19832001 0.78 JAK2 (0.71) JAK2JAK1JAK3TYK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3492468-B1 HETEROCYCLIC COMPOUND AS JAK INHIBITOR, AND SALTS AND THERAPEUTIC USE THEREOF SUZHOU LONGBIOTECH PHARMACEUTICALS CO LTD (CN) 2022-02-23 EP disclosed
EP-3492468-A1 HETEROCYCLIC COMPOUND AS JAK INHIBITOR, AND SALTS AND THERAPEUTIC USE THEREOF Tianjin Longbogene Pharmaceutical Co., Ltd. (CN) 2019-06-05 EP disclosed
WO-2018019222-A1 HETEROCYCLIC COMPOUND AS JAK INHIBITOR, AND SALTS AND THERAPEUTIC USE THEREOF 张文燕 2018-02-01 WO disclosed